Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S > Summary
Court Case Number IPR2023-00724
Filing Date Mar 16, 2023
Court Patent Trial and Appeal Board
Status Trial Instituted
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Petitioner
Patent Owner
Petitioner Attorneys
13Viatris Inc.
Attorney Name: Courtney M. Prochnow
Perkins Coie
Viatris Inc.
Attorney Name: Brandon M. White
Perkins Coie
Viatris Inc.
Attorney Name: Matthew A. Lembo
Perkins Coie
Viatris Inc.
Attorney Name: Jonathan I. Tietz
Perkins Coie
Viatris Inc.
Attorney Name: Emily J. Greb
Perkins Coie
Viatris Inc.
Attorney Name: Christopher D. Jones
Perkins Coie
Viatris Inc.
Attorney Name: John P. Bantle
Perkins Coie
Viatris Inc.
Attorney Name: Paul Dalby
Perkins Coie
Attorney Name: Shannon Bloodworth
Perkins Coie
Attorney Name: David L. Anstaett
Perkins Coie
Attorney Name: Bryan D. Beel
Perkins Coie
Attorney Name: Nathan K. Kelley
Perkins Coie
Attorney Name: Rodney D. Swartz
Perkins Coie
Patent Owner Attorneys
7Novo Nordisk
Attorney Name: Steven Baughman
Groombridge, Wu, Baughman & Stone LLP
Attorney Name: Steven Baughman
Groombridge, Wu, Baughman & Stone LLP
Attorney Name: Michael F. Milea
Groombridge, Wu, Baughman & Stone LLP
Attorney Name: Jenny C. Wu
Groombridge, Wu, Baughman & Stone LLP
Attorney Name: Philip May
Groombridge, Wu, Baughman & Stone LLP
Attorney Name: Joshua Reich
Groombridge, Wu, Baughman & Stone LLP
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10335462 | Use of long-acting GLP-1 peptides | Jul 2, 2019 |
